Meghan Scanlon - 01 May 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP,Pres,Urology Pelvic Health
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 01 May 2022
Net transactions value: -$25,519
Form type: 4
Filing time: 02 May 2022, 16:33:30 UTC
Previous filing: 05 Apr 2022
Next filing: 19 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2,062	+9%	$0.000000	25,067	01 May 2022	Direct	F1
transaction	BSX	Common Stock	Tax liability	$25,519	-606	-2.4%	$42.11	24,461	01 May 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-2,062	-50%	$0.000000	2,062	01 May 2022	Common Stock	2,062		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on May 1, 2020, the first anniversary of the date of grant.